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HeartMate XVE malfunction caused by fluid aspiration into the vent port
Sinan A. Simsir, MD,a Shu S. Lin, MD, PhD,a Myra F. Ellis, RN, MSN,a Stuart D. Russell, MD,b and
Carmelo A. Milano, MD,a Durham, NC
The implantation of a left ventricular assist device(LVAD) provides a clinically meaningful survival ben-efit and better quality of life compared with medicaltherapy in patients with advanced heart failure.1 Mal-
function of the LVAD, however, might significantly reduce the
survival benefit it incurs. Seven of 41 deaths in patients with
LVADs in the REMATCH trial (Randomized Evaluation of Me-
chanical Assistance for the Treatment of Congestive Heart Failure)
were attributed to device malfunction.1 We present the case of a
patient who had an unusual device complication. Fluid was aspi-
rated into the vent port, resulting in the malfunction of the device
and a clinical emergency. A treatment algorithm for this challeng-
ing problem is described.
Clinical Summary
A 55-year-old man (6'5, 183 lb) with idiopathic dilated cardio-
myopathy had a HeartMate XVE (Thoratec Corp, Pleasanton,
Calif) LVAD system implanted. He was convalescing on a step-
down ward 3 weeks postoperatively, with stable LVAD flows of
between 5 and 6 L/min. The patient was incontinent of urine at 5
AM on the day of the event. Urine was aspirated into the LVAD
vent port. The low flow and power limit advisory alarms of the
LVAD activated. The low flow persisted, and the patient became
hemodynamically unstable. The vent filter was immediately re-
moved, and the patient was placed on his right side, enabling fluid
drainage from the vent port. A dry towel was also used to absorb
the remaining fluid at the vent port. After several minutes in this
position, the alarms stopped, and the LVAD flow returned to
previous levels. A new vent filter was placed, and the patient’s
condition remained stable.
The patient experienced the same malfunction again at 9 AM.
The device then stopped, and hand pumping was initiated. Elec-
trical activation was not possible. The patient was systemically
anticoagulated. He was transferred to the intensive care unit, and
arterial line and pulmonary artery catheters were placed for mon-
itoring. The system controller and power source were removed,
and the LVAD was successfully activated with the older pneu-
matic HeartMate driver. This driver was used with a pressure-
limiting device on the pneumatic driveline to avoid injury to the
electric pump, as recommended by the company. The pneumatic
driver rate was increased to 90 beats/min. The patient, however,
remained in shock, and respiratory distress ensued. He was me-
chanically ventilated, and inotropic infusions were initiated to
enhance native ventricular function. Despite these maneuvers, the
patient was hypotensive, with a central venous pressure of 22 mm
Hg and a cardiac output of 2.3 L/min, as measured with the
pulmonary artery catheter and the thermodilution method. Meta-
bolic acidosis was present on the arterial blood gases. The arterial
pressure tracing suggested poor LVAD stroke volume, and native
ventricular ejection confirmed incomplete ventricular unloading by
the pneumatically driven HeartMate LVAD.
A decision was made to replace the LVAD surgically at 11 AM
given the patient’s persistent shock state. At this point, a final
attempt was made to reactivate the pump electrically. Fortunately,
the pump could be electrically activated and subsequently func-
tioned without alarms. The patient’s hemodynamics rapidly nor-
malized: central venous pressure was 8 mm Hg, and cardiac output
increased to 5.3 L/min. The need to surgically replace the pump
was averted. The device continued to function electrically without
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Figure 1. The driveline of the HeartMate XVE LVAD. The arrow
points to the vent port.
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any further events. The patient is in stable condition with good
functional status 3 months postoperatively, having undergone suc-
cessful cardiac transplantation.
Discussion
Pusher plate design implanted LVADs use external venting for air,
which is displaced as the pump fills and aspirated during pump
systole. The HeartMate XVE has a percutaneous driveline, which
consists of the electrical lead and the vent port (Figure 1). Partic-
ulate matter is prevented from entering the vent port by a filter at
the skin. Fluid, however, can pass through the filter into the port
and cause device failure, as experienced in our patient.
This case demonstrates several key points. Aspiration of liquid
into the vent port can result in shutdown of the device. The
inability to electrically drive the pump might be transient or more
sustained. Furthermore, device failure might be temporally de-
layed from the time of the aspiration event. Appropriate maneuvers
in this setting appear to include the following: (1) removal of the
vent filter; (2) positioning of the patient with the right side down
to simply facilitate drainage from the vent port by gravity; (3)
attempt to absorb any liquid at the vent port; (4) systemic antico-
agulation; (5) hand pumping; (6) attachment to the pneumatic
driver; and (7) surgical replacement of the pump.
Notably for this patient, the pneumatic driver failed to achieve
adequate hemodynamics. This is explained by the fact that the
pump stroke volume is significantly reduced if the electric pump is
driven by the old pneumatic driver. Furthermore, excursion of the
pusher plate might be compromised after such fluid aspiration into
the vent port. In fact, on the basis of the cardiac output and
pneumatic driver rate, which was set at 90 beats/min, the pump
stroke volume when driven by the pneumatic driver was only 26
mL. Therefore use of the pneumatic driver might only be a
short-term or incomplete solution. Furthermore, incomplete emp-
tying of the pump with the pneumatic driver might pose a risk of
thromboembolism, emphasizing the need for anticoagulation. Nev-
ertheless, in this case support with the pneumatic driver for 2 hours
Figure 2. Algorithm for management of fluid aspiration into the vent port of the HeartMate XVE. OR, Operating room.
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resulted in elimination of vent port obstruction, such that the pump
could again function electrically. This averted the need for surgical
replacement of the pump. Through this experience, we propose an
algorithm, which might help caregivers with this difficult situation
(Figure 2).
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Surgical management of bilateral multiple invasive
pulmonary aspergillosis
Karin M. Dunst, MD, and Ludwig C. Mueller, MD, Innsbruck, Austria
There are 3 clinical types of pulmonary aspergillosis. Theallergic and saprophytic forms can be encountered inimmunocompetent patients, whereas invasive pulmo-nary aspergillosis (IPA) is a life-threatening opportu-
nistic infectious complication that develops in the immunocom-
promised host as a consequence of impaired defense function.1
IPA represents a major source of morbidity and mortality in the
neutropenic patient. The clinical symptoms are sometimes masked,
especially in the setting of a malignant neoplastic disorder; how-
ever, as a rule, there is productive cough and hemoptysis up to
life-threatening bleeding. Standard therapy consists of amphoter-
icin B, itraconazole, or both2; however, new antifungal agents,
such as voriconazole3 or caspofungin,4 might yield superior ther-
apeutic results. Surgical removal of infected lung tissue is consid-
ered as a therapy of last resort.5
Clinical Summary
A 63-year-old woman received high-dose cortisone therapy be-
cause of a local seroma complication after surgical removal of a
thoracic ependymoma. One month later, she had a septic shock–
like syndrome with acute respiratory insufficiency, requiring oro-
tracheal intubation with 100% oxygen and positive end-expiratory
pressure (10 cm H2O). This management led to a satisfactory
arterial oxygen saturation level (88%). Bronchoalveolar lavage and
sputum cultures revealed Aspergillus fumigatus, and antifungal
therapy with amphotericin B was initiated. Thoracic computed
tomography showed multiple focal cavitary mycotic lesions, with
a cavitary pattern in both of the upper lobes and dense infiltrates in
the lower lobes (Figure 1).
Surgical drainage of the larg-
est cavities was undertaken
because of failure of conser-
vative management. After 8
weeks of antimycotic treat-
ment, we decided to perform
surgical resection. By that
time, the patient was venti-
lated through a tracheostoma,
with intermittent positive airway pressure. In a first operation, a
right upper lobectomy was undertaken (Figure 2). Because of the
patient’s critical condition, a left upper lobe segmental resection
was carried out 4 days later. Furthermore, inflammatory infiltrates
in both lungs were omitted from surgical resection. The postoper-
ative course was uneventful, and the patient was discharged from
the hospital after 10 days for rehabilitation. At 18 months’ follow-
up, the patient has slight exertional dyspnea, and the chest radio-
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Figure 1. Thoracic computed tomogram showing multiple cavi-
tary lesions with surgical drainage in the right upper lobe. Ad-
ditionally, there is a consolidated lesion in the left upper lobe,
with occasional air trapping.
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